2024
Review of the cost-effectiveness of surveillance for hereditary pancreatic cancer
Wang L, Levinson R, Mezzacappa C, Katona B. Review of the cost-effectiveness of surveillance for hereditary pancreatic cancer. Familial Cancer 2024, 23: 351-360. PMID: 38795221, PMCID: PMC11255025, DOI: 10.1007/s10689-024-00392-1.Peer-Reviewed Original ResearchHigh-risk individualsHereditary pancreatic cancerSusceptibility to pancreatic cancerPancreatic cancer riskFamily history of PCSurveillance strategiesPancreatic cancerCost-effectiveness of surveillanceHistory of PCCost-effectiveness studiesCost-effectiveCancer riskCost-effectiveness analysisPancreatic surveillanceHigh-risk groupOptimal surveillance strategyFamily historyNew-onset diabetesRisk individualsSporadic PCHealth benefitsPotential health benefitsPC diagnosisSub-groupsSurveillance
2012
The Prevention and Genetics of Pancreatic Cancer: A Programmatic Approach
Lucas A, Chang M, Lipsyc M, Frucht H. The Prevention and Genetics of Pancreatic Cancer: A Programmatic Approach. Methods In Molecular Biology 2012, 980: 205-214. PMID: 23359155, PMCID: PMC3959119, DOI: 10.1007/978-1-62703-287-2_10.Peer-Reviewed Original ResearchConceptsPredisposition to PCFamily history of PCHistory of PCPancreatic cancerEpidemiology of PCGenetic counselorsImprove screeningHereditary susceptibilityFamily historyHigh-risk patientsStudy investigatorsTreatment of PCProgrammatic approachSkilled teamPC patientsBlood specimensPreventionPatientsPatient tissuesFatal diseasePhysiciansFamilyDiagnostic techniquesOrganize dataEpidemiology
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply